Clinical trials assess new drug or treatment effectiveness and provide cancer patients with the newest and possibly most effective, forms of treatment.
Cancer clinical trials are divided into three different phases. Phase I trials assess the safety of a drug or treatment; phase II trials quantify how effective the treatment is while phase III compares the trial to the best existing cancer treatment.
The decision to participate in a cancer clinical trial should be made early in the diagnosis stage because once treatment begins, patients may not be eligible to participate in certain clinical trials. Benefits of participating in cancer clinical trials include access to the newest treatment and medicine designed to fight your particular type of cancer as well as being monitored closely throughout the treatment process.
Clinical Trial Committee
MOASC is actively working to bridge the gap between academic centers and community practices through Clinical Trial promotion and recruitment. The Clinical Trial Committee was created to determine exactly how to achieve this.
The goals being:
Introduce MOASC to the various research coordinators at the local institutions and community practices.
Establish a safe environment, where everyone can work together without fear of losing patients.
MOASC can assist members with promotion of trials and patient recruitment through the database on website.
Committee Members include:
Kevin Chang, MD, Ventura Hematology Oncology Medical Group
Ashkan Lashkari, MD, Wellness Oncology
Joshua Mansour, MD, City of Hope
Edward McClay, MD, California Cancer Associates for Research & Excellence (CCARE)